Tanveer Farah, Pawlak Joan, Youssef Dima, Saravolatz Louis D
Division of Infectious Disease, Department of Internal Medicine, Ascension St John Hospital, Grosse Pointe Woods, MI, USA.
IDCases. 2021 Jan 9;23:e01045. doi: 10.1016/j.idcr.2021.e01045. eCollection 2021.
We present a case of a 48 years old male with native mitral valve endocarditis. Due to poor growth of the organism, antimicrobial susceptibility test (AST) could not be performed using the CLSI approved method. AST was determined using Etest© strips and the patient was successfully treated with mitral valve replacement and intravenous ceftriaxone.
我们报告一例48岁男性原发性二尖瓣心内膜炎病例。由于病原菌生长不佳，无法使用临床和实验室标准协会（CLSI）批准的方法进行抗菌药物敏感性试验（AST）。采用Etest©试纸条进行AST检测，该患者通过二尖瓣置换术和静脉注射头孢曲松成功治愈。
